Disease Info Card

Bisphosphonate-associated Osteonecrosis

Information about Bisphosphonate-associated Osteonecrosis: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Bisphosphonate-associated Osteonecrosis

Most recent studies have shown that Bisphosphonate-associated Osteonecrosis shares some biological mechanisms with bisphosphonate-associated-osteonecrosis-of-the-jaw, bone-diseases, bone-necrosis, bone-neoplasms, carcinoid-tumor, gastrointestinal-neoplasms, jaw-diseases, malignant-neoplasm-of-breast, malignant-neoplasm-of-prostate, malignant-neoplasms, mammary-neoplasms, mandibular-diseases, metastatic-malignant-neoplasm-to-the-bone, multiple-myeloma, neoplasm-metastasis, neoplasms, neuroendocrine-tumors, osteoporosis, pain, pancreatic-neoplasm.

Among the many pathways, these few ones have gauged particular interests from scientists studying Bisphosphonate-associated Osteonecrosis, and have been seen in publications frequently: Angiogenesis, Bone Remodeling, Bone Resorption, Cell Cycle, Cell Cycle Arrest, Cell Death, Cell Growth, Cell Proliferation, Endoderm Formation, Exocytosis, Gastrulation, Hormone Secretion, Induction Of Apoptosis, Nodal Signaling Pathway, Pathogenesis, Peptide Secretion, Regeneration, Secretion, Transport, Wound Healing

Quite a number of genes have been found to play important roles in Bisphosphonate-associated Osteonecrosis, such as AKT1, ASCL1, ELANE, FUT3, GATA5, GNAI1, GRP, HPS4, IFNA1, MAP2K1, MAPK1, MAPK3, NODAL, NT5E, NTM, NTS, PIK3CA, PRKD1, SST. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.